MPDD – Revolutionary Pain Management Device – FDA 510k Cleared
Americans spend over $85 billion dollars annually on treatment for chronic back pain. Much of this money is wasted on failed surgeries and misdiagnosis. In fact, the medical industry has a term for this; “FBSS” or Failed Back Surgery Syndrome. Medicare is charged billions of dollars annually for these failures. Both Physicians and Medicare are desperately in need of a better diagnosis tool for chronic back pain and muscular pain. The MPDD device is a developed clinical and technological platform that promises to greatly increase the accuracy with which muscle pain is diagnosed and drive down health care costs associated with chronic pain. EPGL Med has set forth to capitalized on an opportunity to work with leading pain management physicians, on marketing a medical device to facilitate a revolutionary method for pain diagnosis. The MPDD has received FDA 510K clearance for marketing and manufacture.
The combined national and international market for the MPDD device is estimated at $4.5 billion dollars annually in device sales and recurrent education and training revenues. The primary market will be pain management physicians and primary care physicians. This market will then expand to sports medicine and physical therapists. Ideally the DHS MPDD device will be as common as the stethoscope in a physician’s hand. Signaling a new era in pain diagnosis where the idea of chronic muscle pain will be virtually nonexistent.
The MPDD does not compete with current methods of pain diagnosis. Instead, MPDD will enhance current methods of diagnosis and treatment. Thus, helping realize the full value of current diagnostic tools such as MRI, CT scan, X-ray standard physical examination.
MPDD will compliment the pharmaceutical industry by helping doctors to properly correlate the prescription of painkillers to the correct source of pain. This may help patients achieve lasting relief by pharmaceutics alone, rather than more drastic procedures such as surgery.
MPDD incorporates two technologies, one of clinical methodology and one for device technology, for a combined diagnostic package that allows for a revolution in the accuracy and precision of muscle pain diagnosis. The first is a diagnostic method developed over 50 years by a series of key opinion leaders in pain management. The patented version of this methodology allows for the diagnosis of muscles in a dynamic, natural, state (as opposed to static). This simple feature greatly increases the precision of the diagnosis while the unique methodology provides isolation of the pain generator, increasing accuracy. The MPDD device incorporates leading edge technology for trans-cutaneous-electroneural stimulation, a safe, effective and proven way of stimulating muscle. The patented method and the MPDD device are inherently linked, a powerful innovation in the management of chronic pain.
MPDD – Revolutionary Pain Management Device – FDA 510k
Top 10 Most Recent News Articles
New Congressional Guide Aims to Aid Companies' Strategies
Fresh Faces, New Dynamics: Navigating the 120th Congress Wake up and smell the Capitol Hill grind, folks. We've got the 120th Congress on our hands, brimming with fresh faces and a colossal shift in the political landscape. Thanks to our pals at Marathon Strategies, we've been thrown a bone with 'Meet The Freshmen'—a nonpartisan rundown of the latest political...
Continue ReadingDatavations Unveils Test Tracker for Home Improvement
Unearthing the Strategic Gold Datavations has launched something that could be a real game-changer for home improvement suppliers—a tool called the Store Test Tracker. This thing zeros in on limited-distribution SKU tests happening in the giant playgrounds of Home Depot, Lowe's, and Menards. You think small-scale trials don't matter? Buckle up, because sometimes the...
Continue Reading
Hyster-Yale Navigates a Rocky Q3 2026 Recovery
Imagine Hyster-Yale like a battered ship in a stormy market, steering its way towards stability with a few promising signals on the horizon. Despite a 15% dip in revenue compared to last year, they're celebrating a hefty boost in bookings—up 45% from the rough waters of Q2 2025. It's a mixed bag of tales from the latest quarterly results that might have you scratching...
Continue Reading
Democracy's Living History at Long Island University
America’s democracy is getting its moment in the spotlight over at Long Island University, and it's more than just statues and old papers. This exhibition, "The Presidency & Promise of America: A More Perfect Union," unpacked on October 28, throws open a window into the U.S.'s democratic journey from its scrappy beginnings to today’s hot zones of political debate. And...
Continue Reading
Tucows Shows Progress in Q3 2026 Amidst Net Loss
Q3 Snapshot: Balancing Act at Tucows Man, if there's one thing you can count on from Tucows, it's that they'll shuffle the deck just when you're getting comfortable. Here in the third quarter of 2026, they've managed a decent juggling act. Their unaudited numbers show consolidated net revenue ticking up 1.4% from last year, rounding out at a cool $100 million. That's...
Continue Reading
Priority Software Acquires Fireberry to Boost AI Vision
Another Big Play in the AI-Driven Business Landscape Here we go, folks. Priority Software just made a move that's gonna shake up the AI business management scene. They’ve acquired Fireberry, a CRM company that's seen some success in the AI world. Now, this ain't just some small-scale adjustment; it's an all-in bet on AI to bolster their existing platforms. What's...
Continue Reading
Breeze Airways Secures $228M for Fleet Expansion
Breeze Airways and AIP's Milestone Deal Just as the ink is drying on the balance sheets, Breeze Airways is busy making significant moves in the aviation game. Partnering with AIP Capital, they just locked in a $228 million secured debt facility to grab six new Airbus A220-300 aircraft. Now, that’s how you stake your claim in the market. What we’ve got here isn’t...
Continue Reading
New Pool Ladder Standard Aims to Curb Child Drownings
Cracking Down on Pool Safety Gaps Toddlers and pools—a mix as risky as leaving your car keys with a teenager. The U.S. Consumer Product Safety Commission (CPSC), alongside ASTM International, has rolled out a tighter safety standard for above-ground pool ladders. This isn't just bureaucracy in action; it's about saving young lives from the grim statistics of...
Continue Reading
Harbour BioMed's Strategic Nudge with Vivian Feng Hire
A Refreshing Jolt for Harbour BioMed's Growth Journey Harbour BioMed just threw down a new card by bringing in Ms. Vivian Feng as the Senior Vice President, Head of External Collaboration. There's a real sense of drive coming from this decision. When a biopharma outfit asserts its intent to ramp up growth, and they hang the hat on someone like Vivian, you better believe...
Continue Reading
Xinjiang Co-op Elevates Walnut Farmers, Markets Expand
From the Gobi Desert to the Global Market You ever hear about walnuts from the Gobi Desert? It sounds like a tale spun over too many drinks, but here we are, talking about folks in Xinjiang crafting an empire out of nuts. Not just any nuts, mind you—walnuts, lovingly nurtured under the sun and cold nights in Kuqa. They’ve carved out a niche in a corner of the world...
Continue ReadingTop 5 Most Recently Viewed Articles
Christine Russell's Stock Options Move at eGain: What You Should Know
Christine Russell's Stock Option Exercise at eGain In a recent filing with the SEC, it was disclosed that Christine Russell, a Board Member at eGain, executed an options exercise that ended up realizing no monetary gain due to the exercise price being set at $0.0. This move raised eyebrows among investors as it was worth 0 shares of the company, painted against eGain's...
Continue Reading
Crown Castle's Q3 2024 Earnings: Growth and Strategic Initiatives
Performance Highlights from Crown Castle's Q3 2024 Crown Castle International Corp. (NYSE: CCI) delivered a commendable performance in its third quarter of 2024, showcasing its resilience in the competitive telecommunications sector. The company maintained its full-year outlook for adjusted EBITDA and AFFO while anticipating consolidated organic revenue growth of...
Continue Reading
Alliance Pharma: Significant Recent Activity in Trading
Overview of Recent Trading Activity at Alliance Pharma In the landscape of finance, keeping track of significant trading activities is paramount for stakeholders. This is especially true for companies like Alliance Pharma plc, known for their strategic initiatives that directly impact the market. Recently, important disclosures related to trading have captured the...
Continue Reading
Wall Street Surges as Major Corporations Drive Optimism
Wall Street's Historic Rally Wall Street has witnessed an impressive rally lately, with significant benchmarks like the S&P 500 and the Nasdaq 100 soaring to all-time highs. This upward momentum is largely attributed to robust corporate earnings, positive economic indicators, and a growing enthusiasm for technology, particularly driven by advancements in artificial...
Continue Reading
AKVA Group ASA: Insights Await as Q3 2025 Results Unveiled
Invitation to Q3 2025 Financial Results Presentation AKVA group ASA is excited to extend an invitation for the presentation of its Q3 2025 financial results. This is an excellent opportunity for investors, stakeholders, and anyone interested in understanding the company's performance during this period. Presentation Details The presentation is scheduled for Friday,...
Continue Reading